389 related articles for article (PubMed ID: 19696673)
1. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
Ballard C; Corbett A; Chitramohan R; Aarsland D
Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
[TBL] [Abstract][Full Text] [Related]
2. Agitation and aggression in people with Alzheimer's disease.
Ballard C; Corbett A
Curr Opin Psychiatry; 2013 May; 26(3):252-9. PubMed ID: 23528917
[TBL] [Abstract][Full Text] [Related]
3. Management of agitation and aggression associated with Alzheimer disease.
Ballard CG; Gauthier S; Cummings JL; Brodaty H; Grossberg GT; Robert P; Lyketsos CG
Nat Rev Neurol; 2009 May; 5(5):245-55. PubMed ID: 19488082
[TBL] [Abstract][Full Text] [Related]
4. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
5. Psychotic symptoms, aggression and restlessness in dementia.
Ballard C; Gray A; Ayre G
Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
[TBL] [Abstract][Full Text] [Related]
6. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
7. Treatment of behavioral and psychological symptoms of Alzheimer's disease.
Corbett A; Smith J; Creese B; Ballard C
Curr Treat Options Neurol; 2012 Apr; 14(2):113-25. PubMed ID: 22328204
[TBL] [Abstract][Full Text] [Related]
8. Management of neuropsychiatric symptoms in people with dementia.
Ballard C; Corbett A
CNS Drugs; 2010 Sep; 24(9):729-39. PubMed ID: 20806986
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological treatment of behavioral symptoms in dementia patients].
Gabryelewicz T
Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatment of dementia.
Schwarz S; Froelich L; Burns A
Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
Cummings JL; Mackell J; Kaufer D
Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
[TBL] [Abstract][Full Text] [Related]
13. [Recognition and treatment of behavioral and psychological symptoms of dementias: lessons from the CATIE-AD study].
Kálmán J; Kálmán S; Pákáski M
Neuropsychopharmacol Hung; 2008 Oct; 10(4):233-49. PubMed ID: 19213202
[TBL] [Abstract][Full Text] [Related]
14. Treatment of dementia: anything new?
Machado JC; Caramelli P
Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
[TBL] [Abstract][Full Text] [Related]
15. Current issues in dementia pharmacotherapy.
Daiello LA
Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic dose-sparing effect with addition of memantine.
Sleeper RB
Ann Pharmacother; 2005 Sep; 39(9):1573-6. PubMed ID: 16076907
[TBL] [Abstract][Full Text] [Related]
17. Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits.
Moretti R; Torre P; Antonello RM; Pizzolato G
Expert Rev Neurother; 2006 May; 6(5):705-10. PubMed ID: 16734518
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
Omerovic M; Hampel H; Teipel SJ; Buerger K
World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
[TBL] [Abstract][Full Text] [Related]
19. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.
Eustace A; Coen R; Walsh C; Cunningham CJ; Walsh JB; Coakley D; Lawlor BA
Int J Geriatr Psychiatry; 2002 Oct; 17(10):968-73. PubMed ID: 12325059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
